GASTRIC ADENOCARCINOMA
Clinical trials for GASTRIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTRIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Study tests timing of chemo for stomach cancer
Disease control TerminatedThis study aimed to compare two different timing schedules for chemotherapy in people with stomach or gastroesophageal junction cancer. It tested whether giving all chemotherapy before surgery works better than the standard approach of giving some before and some after surgery. T…
Matched conditions: GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Radical surgery trial for advanced stomach cancer halted early
Disease control TerminatedThis study aimed to see if adding surgery to remove the main stomach tumor and a single metastatic site to standard chemotherapy helps patients with a limited spread of stomach cancer live longer and feel better than chemotherapy alone. It was a large, randomized Phase 3 trial, b…
Matched conditions: GASTRIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New pill targets genetic weakness in advanced cancers
Disease control TerminatedThis early-stage study tested a new oral drug called PRT7732 in people with advanced or metastatic solid tumors that have a specific genetic change (SMARCA4 mutation). The main goals were to find a safe dose, see how the body processes the drug, and look for early signs that it m…
Matched conditions: GASTRIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Two-Pronged attack tested for tough cancers
Disease control TerminatedThis study tested whether combining two drugs, niraparib and dostarlimab, could help control advanced cancers that had specific genetic problems or were previously sensitive to platinum chemotherapy. It involved 51 adults with various cancers, including bladder, stomach, and kidn…
Matched conditions: GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug combo tested in fight against advanced stomach cancer
Disease control TerminatedThis study tested whether adding an experimental drug called DKN-01 to a standard immunotherapy (tislelizumab) and chemotherapy could better control advanced stomach or gastroesophageal cancer. It involved about 247 adults whose cancer could not be removed by surgery. The main go…
Matched conditions: GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Leap Therapeutics, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC